Vista Pharmaceuticals Ltd — Board Meeting, 14-08-2026: Board Meeting
14-08-2026 | 03:36 pm
14-08-2026 | 03:36 pm
Vista Pharma's Board approved Q1 results, showing a net loss of Rs. 0.99 Cr with Nil revenue. Facing significant 'going concern' doubts due to NPA and negative working capital, the company expects Rs. 9.22 Cr from warrant subscribers to support operations.
No comments yet. Be the first to comment!
